CAM
NVO

ClariVest Asset Management’s Novo Nordisk NVO Stock Holding History

ClariVest Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.92K Hold
41
– – ﹤0.01% 442
2024
Q2 		$5.92K Hold
41
– – ﹤0.01% 442
2024
Q1 		$5.25K Hold
41
– – ﹤0.01% 457
2023
Q4 		$4.24K Buy
+41
New +$4.05K ﹤0.01% 471

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClariVest Asset Management's NVO Position: Q3 2024 in Review

ClariVest Asset Management held its Novo Nordisk (NVO) position steady in Q3 2024 at 41 shares worth $5.92K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

ClariVest Asset Management first reported a position in NVO in Q4 2023 and has held it in 4 quarters since. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • ClariVest Asset Management held 41 shares of Novo Nordisk worth $5.92K as of Q3 2024.
  • ClariVest Asset Management left its Novo Nordisk share count unchanged in Q3 2024.
  • Novo Nordisk made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #442 holding.
  • ClariVest Asset Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 4 quarters since.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.